IRIX_OUT_1 [2025-03-21 14:12:46 -0400] 2022 Bytes | 584 tokens | Cum: 584 tkns (7.30% of 8k)
==========================================================================

Turbo, you got one job - predict the hottest stocks of the day -- before everyone else does! Ha! So today we're looking at Iridex (IRIX) which is at 0.9503 up from 0.7901. So, I pulled together a bunch of data for you to look over real fast. It's still early, 2:12:45 PM on Fri Mar 21, 2025 -0400. So, what's the verdict? You're the expert!

Here's the first list of news for Iridex:

C1 - Mar-19-25 09:15AM - Iridex Announces Strategic Investment in the Company
C2 - Mar-14-25 07:00AM - Iridex Comments on Recent Stock Price Volatility
C3 - Mar-13-25 05:00PM - Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025
C4 - Jan-14-25 07:24AM - Iridex: Q4 Sales To Match Performance Of Prior Year
C5 - Jan-14-25 07:24AM 07:00AM - Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2024
C6 - Dec-18-24 04:05PM - Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management
C7 - Nov-19-24 08:14AM - Iridex Comments on Changing Glaucoma Reimbursement Landscape
C8 - Nov-13-24 02:20AM - IRIDEX Corp (IRIX) Q3 2024 Earnings Call Highlights: Strategic Moves and Glaucoma Growth Amid ...

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Iridex (IRIX)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

IRIX_OUT_3 [2025-03-21 14:12:50 -0400] 1045 Bytes | 274 tokens | Cum: 860 tkns (10.75% of 8k)
==========================================================================

Showing C1 (chunk 1 of 8): C1:
**Iridex Announces Strategic Investment in the Company**
Date: Mar-19-25 09:15AM
Source: (GlobeNewswire)
URL: https://www.globenewswire.com/news-release/2025/03/19/3045492/0/en/Iridex-Announces-Strategic-Investment-in-the-Company.html

March 19, 2025 09:15 ET| Source:IRIDEX CorporationIRIDEX Corporation

MOUNTAIN VIEW, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for the treatment of glaucoma and retinal diseases, today announced the closing of a strategic investment in the company resulting in $10 million of gross proceeds along with an option by the investor to fund up to $10 million of additional proceeds for future growth initiatives (the “Transaction”). The sole counterparty to the Transaction is Novel Inspiration International Co., Ltd. (“Nov

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

IRIX_OUT_5 [2025-03-21 14:12:51 -0400] 835 Bytes | 247 tokens | Cum: 1109 tkns (13.86% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-19T13:17:23Z - Iridex Announces Strategic Investment in the Company...
A2 - 2025-03-19T13:17:23Z - Iridex Announces Strategic Investment in the Company...
A3 - 2025-03-19T13:29:17Z - Iridex Announces Strategic Investment in the Company | Taiwan News | Mar. 19, 2025 21:15...
A4 - 2025-03-19T13:15:00Z - Iridex Announces Strategic Investment in the Company...
A5 - 2025-03-19T13:27:07Z - Iridex Announces Strategic Investment in the Company...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

IRIX_OUT_7 [2025-03-21 14:12:53 -0400] 1038 Bytes | 271 tokens | Cum: 1382 tkns (17.27% of 8k)
==========================================================================

Showing A1 (chunk 1 of 2): A1:
**Iridex Announces Strategic Investment in the Company**Date: 2025-03-19Source: {'uri': 'eagletribune.com', 'dataType': 'news', 'title': 'Eagle-Tribune'}URL: https://www.eagletribune.com/region/iridex-announces-strategic-investment-in-the-company/article_123b4767-b699-5a37-a568-91177c162d61.htmlMOUNTAIN VIEW, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for the treatment of glaucoma and retinal diseases, today announced the closing of a strategic investment in the company resulting in $10 million of gross proceeds along with an option by the investor to fund up to $10 million of additional proceeds for future growth initiatives (the "Transaction"). The sole counterparty to the Transaction is Novel Inspiration International Co., Ltd. ("Novel"), an inv

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

IRIX_OUT_9 [2025-03-21 14:12:57 -0400] 805 Bytes | 175 tokens | Cum: 1559 tkns (19.49% of 8k)
==========================================================================

Showing A1 (chunk 2 of 2): estment company founded in 2020, which had the assistance of William Moore, formerly both a board member and Chief Executive Officer of the company.

The portion of the Transaction that closed today involves the sale of $6 million of new Series B Preferred Stock (the "Series B Preferred") and $4 million in aggregate principal amount of notes convertible into Series B Preferred. Pursuant to the Transaction documents, Iridex and Novel will jointly pursue growth initiatives which may result, at Novel's election, in the issuance of an additional $10 million in aggregate principal amount of notes (the "Growth Notes") convertible into common stock of the company.

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

IRIX_OUT_11 [2025-03-21 14:12:58 -0400] 867 Bytes | 295 tokens | Cum: 1938 tkns (24.22% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2025-03-14T11:00:00Z - Iridex Comments on Recent Stock Price Volatility
B2 - 2025-03-13T21:00:00Z - Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025
B3 - 2025-01-17T01:15:00Z - Medical Lasers Market Size is Projected to Reach USD 12.02 billion by 2033, Growing at a CAGR of 9.10%: Straits Research
B4 - 2024-12-16T16:52:00Z - Ophthalmic Lasers Market, Competitive Landscape and Market Forecasts to 2030
B5 - 2024-05-14T22:00:04Z - Iridex (IRIX) Reports Q1 Loss, Misses Revenue Estimates
B6 - 2024-05-06T21:30:04Z - Lumentum (LITE) Q3 Earnings Beat Estimates

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

IRIX_OUT_13 [2025-03-21 14:13:02 -0400] 634 Bytes | 185 tokens | Cum: 2125 tkns (26.56% of 8k)
==========================================================================

Showing B2 (chunk 1 of 1): B2:
**Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2025/03/13/3042638/0/en/Iridex-to-Report-Fourth-Quarter-and-Full-Year-2024-Financial-Results-on-March-27-2025.htmlIridex Corporation, a leader in laser-based medical systems for ophthalmology, announces plans to release its Q4 and full-year 2024 financial results and provide a business update on March 27, 2025.

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

IRIX_OUT_15 [2025-03-21 14:13:03 -0400] 1083 Bytes | 308 tokens | Cum: 2491 tkns (31.14% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S3 - 2025-03-19 8-K Item 1.01. Entry Into a Material Definitive Agrmt.

On March 19, 2025, IRIDEX Corporation, a Delaware corporation (the Company) entered into the Securities Purchase Agrmt (the Securities Agrmt) and the Note Purchase Agrmt (the Note Purchase Agrmt, and togethe...

S4 - 2025-01-14 8-K Item 2.02.Results of Oper and Fin Cond.

On January 14, 2025, IRIDEX Corporation (the "Company") announced its preliminary, unaudited operational and financial results for its fourth fiscal quarter and full fiscal year ended December 28, 2024. The press release ...

S5 - 2024-11-12 10-Q PART I. FINANCI AL INFO

Item 1. Condensed Cons F inancial Stmnts (Unaudited)

IRIDEX Corporation

COND CONSOLIDA TED BAL SHEETS

(Unaudited, in thousands except share and per share data)

September 28, 2024

December 30, 2023

ASSETS

Curr...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

IRIX_OUT_17 [2025-03-21 14:13:08 -0400] 837 Bytes | 199 tokens | Cum: 2692 tkns (33.65% of 8k)
==========================================================================

Showing S4 (chunk 1 of 1): S4:
Item 2.02.Results of Operations and Financial Condition.

On January 14, 2025, IRIDEX Corporation (the "Company") announced its preliminary, unaudited operational and financial results for its fourth fiscal quarter and full fiscal year ended December 28, 2024. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.

This information shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing....

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

IRIX_OUT_19 [2025-03-21 14:13:35 -0400] 4344 Bytes | 1222 tokens | Cum: 4008 tkns (50.10% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+--------------------+-----------------------+----------------------+-------------------------+------------------------+----------------------+
| Volume: 119,055 | SMA50: -32.98% | Market Cap: 16.07M | Option/Short: Yes / Yes | Sales past 5Y: 7.17% | Sales Surprise: - |
+--------------------+-----------------------+----------------------+-------------------------+------------------------+----------------------+
| Avg Volume: 58.58K | SMA200: -44.64% | Shs Outstand: 16.64M | Short Float: 2.18% | Employees: 111 | EPS Surprise: - |
+--------------------+-----------------------+----------------------+-------------------------+------------------------+----------------------+
| Rel Volume: 2.91 | Perf Week: -14.48% | Shs Float: 12.23M | Short Ratio: 4.55 | Debt/Eq: 1.87 | P/E: - |
+--------------------+-----------------------+----------------------+-------------------------+------------------------+----------------------+
| RSI (14): 37.19 | Perf Month: -36.42% | Inst Own: 19.41% | Short Interest: 0.27M | Sales Y/Y TTM: -11.31% | Earnings: Mar 27 AMC |
+--------------------+-----------------------+----------------------+-------------------------+------------------------+----------------------+
| ATR (14): 0.13 | Perf Quarter: -42.48% | Insider Own: 26.47% | Beta: 0.80 | ROE: -150.28% | |
+--------------------+-----------------------+----------------------+-------------------------+------------------------+----------------------+
| SMA20: -18.49% | Index: - | Insider Trans: 0.00% | Sales Q/Q: -9.88% | ROI: -211.34% | |
+--------------------+-----------------------+----------------------+-------------------------+------------------------+----------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

No transactions recorded.

No transactions recorded.

[Company Financial Summary]
[Company Details]
Name: Iridex Corp
Market Cap: 13392285.9
Shares Outstanding: 16636380
Sector: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 48431000.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -11036000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 0.9758
Average Volume: 93622.83
30-Day High: 1.52
30-Day Low: 0.7901

[Detailed Financials: Q3 2024]
- Total Assets: $30,154,000.0
- Total Liabilities: $27,531,000.0
- Total Equity: $2,623,000.0
- Current Assets: $24,337,000.0
- Current Liabilities: $15,852,000.0

[Income Statement: Q3 2024]
- Revenue: $11,581,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.12

[Cash Flow Statement: Q3 2024]
- Net Cash Flow: $-3,228,000.0

[Detailed Financials: Q2 2024]
- Total Assets: $31,249,000.0
- Total Liabilities: $27,003,000.0
- Total Equity: $4,246,000.0
- Current Assets: $25,007,000.0
- Current Liabilities: $16,145,000.0

[Income Statement: Q2 2024]
- Revenue: $12,631,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.16

[Cash Flow Statement: Q2 2024]
- Net Cash Flow: $0
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

IRIX_OUT_21 [2025-03-21 14:13:38 -0400] 676 Bytes | 167 tokens | Cum: 4457 tkns (55.71% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

IRIX_IN_23 [2025-03-21 14:13:38 -0400] 126 Bytes | 29 tokens | Cum: 4514 tkns (56.43% of 8k)
==========================================================================

====================================
[2025-03-21 11:13:38] # Analysis Completed
Elapsed Time: 53.87 seconds